Abstract Missense variants are a major source of human genetic variation. Here we analyze a new mouse missense variant, Rasgrp1
Introduction
Positive and negative selection of thymocytes generates a population of T lymphocytes with a broad spectrum of antigen-specific T cell receptors (TCR) Kortum et al., 2013) . It was recognized early on that the small GTPase Ras plays a role (Swan et al., 1995) . Three Ras guanine exchange factor (RasGEF) families can activate Ras: SOS, RasGRP, and RasGRF (Stone, 2011) . Following TCR engagement, Son of Sevenless (SOS)-1 and -2 are recruited to the plasma membrane via a Grb2-phospho-LAT interaction. Simultaneously, the second messenger diacylglycerol (DAG), generated via PLCγ, directly recruits Ras guanine nucleotide releasing protein 1 (Rasgrp1) to the plasma membrane (Ebinu et al., 1998) . Biochemically, Rasgrp1 and SOS1 synergize to induce high-level Ras activation (Roose et al., 2007) and Rasgrp1 serves a critical role in priming SOS1 via Rasgrp1-produced RasGTP (Das et al., 2009) . Consequentially, thymocyte development is severely impaired in Rasgrp1-deficient mice (Dower et al., 2000) , and not compensated for by SOS RasGEFs. Additionally, there is only minimal compensation for loss of Rasgrp1 coming from Rasgrp3 or Rasgrp4 Golec et al., 2013) . Rasgrp1-deficient mice exhibit a strong defect in positive selection and impaired ERK phosphorylation in thymocytes (Dower et al., 2000; Priatel et al., 2002) . The importance of the canonical Rasgrp1-RasGTP-RAF-MEK-ERK pathway for developing thymocytes is further underscored by impaired positive selection in ERK-1 and -2 doubly deficient mice (Fischer et al., 2005) .
Although Rasgrp1 plays a critical role in the activation of Ras, relatively little is known about its regulation in T lymphocytes or the in vivo importance of such regulation. In addition to membrane recruitment via its DAG-binding C1 domain (Ebinu et al., 1998 ), Rasgrp1's GEF activity is enhanced by inducible phosphorylation of threonine 184 (Roose et al., 2005; Zheng et al., 2005) . Phospholipase C γ (PLCγ) not only generates DAG but also inositol 1,4,5-trisphosphate (IP3), which binds to IP3 receptors on the endoplasmic reticulum to activate the calcium pathway (Feske, 2007) . Interestingly, Rasgrp1 also contains a pair of EF hands, motifs that often bind calcium, which induces conformational changes (Gifford et al., 2007) . Rasgrp1 has been reported to bind calcium in vitro (Ebinu et al., 1998) . In chicken DT40 B cells, the first EF 1 domain enables the recruitment function of a C-terminal PT domain (plasma membrane targeting domain) that cooperates with the C1 domain to recruit Rasgrp1 to the membrane (Tazmini et al., 2009) . Notably, the PT domain contribution is substantial in BCR-stimulated B cell lines, very modest in T cell lines, and negligible in fibroblasts (Beaulieu et al., 2007) . Genetic deletion of Rasgrp1's 200 C-terminal amino acids reduces the formation of mature thymocytes in Rasgrp1 d/d mice (Fuller et al., 2012) . Our recent structural studies revealed that Rasgrp1's C terminus contains a coiled-coil dimerization domain (Iwig et al., 2013) . Rasgrp1 dimerization plays eLife digest Our DNA contains more than three billion nucleotides. Each of these nucleotides can be an A, C, G or T, and groups of three neighboring nucleotides within our DNA are used to represent the 20 amino acids that are used to make proteins. This means that changing just one nucleotide can cause one amino acid to be replaced by a different amino acid in the protein encoded by that stretch of DNA: AAA and AAG code for the amino acid lysine, for example, but AAC and AAT code for asparagine. Known as missense gene variants, these changes can also increase or decrease the expression of the gene.
Every person has thousands of missense gene variants, including about 12,000 inherited from their parents. Sometimes these variants have no consequence, but they can be harmful if replacing the correct amino acid with a different amino acid prevents the protein from performing an important task. In particular, missense gene variants in genes that encode immune system proteins are likely to play a role in diseases of the immune system. For example, variants near a gene called Rasgrp1 have been linked to two autoimmune diseases -type 1 diabetes and Graves' disease-in which the immune system mistakenly attacks the body's own cells and tissues. Now Daley et al. have shed new light on the mechanism by which a missense gene variant in Rasgrp1 can cause autoimmune diseases. Mice with this mutation show signs of autoimmune disease, but their T cells-white blood cells that have a central role in the immune system -develop normally despite this mutation. Instead, Daley et al. found that a specific type of T cell, called T helper cells, accumulated in large numbers in the mutant mice and stimulated cells of a third type-immune cells called B cells-to produce autoantibodies. The production of autoantibodies is a common feature of autoimmune diseases.
Daley et al. traced the origins of the T helper cells to excessive activity on a signaling pathway that involves a protein called mTOR, and went on to show that treatment with the drug rapamycin counteracted the accumulation of the T helper cells and reduced the level of autoimmune activity. In addition to exemplifying how changing just one amino acid change can have a profound effect, the work of Daley et al. is an attractive model for exploring how missense gene variants in people can contribute to autoimmune diseases.
an important role in controlling Rasgrp1's activity; the second EF hand of one Rasgrp1 molecule packs against the C1 domain of a second molecule in a manner that is incompatible with DAG-binding whereas calcium binding to the first EF hand is predicted to unlock this autoinhibitory dimer interface (Iwig et al., 2013) . Lastly, it is unknown if Rasgrp1 may signal to pathways other than the canonical Rasgrp1-Ras-RAF-MEK-ERK cascade, although a link between Rasgrp1 and mTOR (mechanistic target of rapamycin) signaling has been proposed (Gorentla et al., 2011) .
Older Rasgrp1-deficient and Rasgrp1 d/d mice (Fuller et al., 2012 ) develop splenomegaly and autoantibodies. In these mouse models, the complete deletion or truncation of Rasgrp1 greatly decreases T cell development in the thymus (Dower et al., 2000; Fuller et al., 2012) , resulting in peripheral T cell lymphopenia followed by accumulation of CD44 hi CD62L lo CD4 + T cells (Priatel et al., 2007; Fuller et al., 2012) . Autoimmune phenotypes caused by these mutations have been attributed to compromised T cell selection in the thymus and compensatory expansion of peripheral T cells in response to lymphopenia and/or chronic infection. Hypomorphic missense alleles of the signaling molecules ZAP-70 and LAT also impair T cell development in the thymus and culminate in severe peripheral immune dysregulation. For example, an SKG allele of the kinase ZAP-70 has reduced binding-affinity for phospho-TCRζ and leads to autoimmune arthritis in mice (Sakaguchi et al., 2003) . Point mutations in ZAP70's catalytic domain that reduce kinase activity to intermediate levels diminish thymic deletion and Foxp3 + Treg differentiation but preserve peripheral T cell activation, resulting in autoantibody formation and hyper-IgE production (Siggs et al., 2007) . Mutation of a single tyrosine in LAT (LAT
Y136F
) results in hyperproliferative lymphocytes of a T H 2 type (Aguado et al., 2002; Sommers et al., 2002) . In each of these cases, peripheral T cell dysregulation is tied to, and potentially explained by, profound deficits in thymic T cell formation.
Single nucleotide variants that cause amino acid substitutions (missense variants; SNVs) or modify the level of gene expression rather than knocking out protein expression are a major form of human genetic variation: most people inherit ∼12,000 missense gene variants (The 1000 Genomes Project Consortium, 2010 . Given the emerging examples of missense alleles having very different immunological consequences from null alleles, mouse models that analyze the consequences of missense variants in key immune genes are needed to understand the pathogenesis of complex human immune diseases. Common tag SNVs near RASGRP1 are associated with susceptibility to autoimmune (Type 1) diabetes and to thyroid autoantibodies in Graves' disease (Qu et al., 2009; Plagnol et al., 2011) , while 13 unstudied RASGRP1 missense SNVs are currently listed in public databases. A fruitful approach for identifying missense gene variants that dysregulate immune function has been through N-ethyl-N-nitrosourea (ENU) mutagenesis (Nelms and Goodnow, 2001 ). Here we describe the analysis of a novel ENU-induced missense variant, Rasgrp1
Anaef that reveals an important in vivo regulatory function of Rasgrp1's EF hands.
Rasgrp1
Anaef is distinct from previously described autoimmune mutations in Rasgrp1, Zap70 or Lat, as Rasgrp1
Anaef has no detectable effect on thymocyte development in mice with normal TCR repertoires, but results in peripheral accumulation of a distinct population of Helios + PD-1 + T-helper cells and production of anti-nuclear autoantibodies. In contrast to Rasgrp1 deletion, the Rasgrp1 Anaef missense variant increases tonic mTOR signaling in naïve CD4 + T cells. Genetic reduction of mTOR function in Rasgrp1
Anaef mice normalizes CD44 expression on naïve CD4 + T cells and abolishes excessive accumulation of effector T cells and autoantibodies, demonstrating a central role for increased mTOR activity in driving immune dysregulation in Rasgrp1 Anaef mice.
Results

Identification of the Rasgrp1
Anaef mouse strain with a mutated EF hand in Rasgrp1
As part of a mouse genome-wide screen for immune phenotypes induced by ENU mutagenesis (Nelms and Goodnow, 2001) , we identified a variant C57BL/6 (B6) pedigree displaying elevated frequencies of CD44 hi CD4 + cells ( Figure 1A ), elevated CD44 expression on naïve FOXP3 − CD44 lo CD4 + cells ( Figure 1B ) and antinuclear antibodies (ANAs) staining with a homogeneous nuclear pattern ( Figure 1C,D) . The elevated frequency of CD44 hi cells trait, which occurred at a frequency consistent with inheritance of a recessive gene variant ( Figure 1A) , was used to map the mutation in an F2 intercross to an interval between 114 and 121.2 Mb on chromosome 2 (Figure 1-figure supplement 1A) .
Sequencing of the exons of Rasgrp1, the only gene within this interval with a known immune function, identified an A to G missense mutation in codon 519 within exon 13 (Figure 2A ). Whole-exome capture, sequencing and computational analysis of DNA from an affected mouse (Andrews et al., 2012) identified this mutation as the only novel single-nucleotide variant within the interval of interest on chromosome 2 (data not shown). The mutant codon, located in Rasgrp1's second EF hand (EF2), encodes a neutral amino acid glycine (G) instead of the normal arginine (R) , a large polar molecule with a positive charge (Rasgrp1 R519G; Figure 2A ,B). Rasgrp1's arginine residue at 519 is also found in Rasgrp-2, and -4, and in EF3 of calcium and integrin binding protein (CIB) ( Figure 2B ). EF hands typically come in pairs separated by a linker and calcium binding subsequently alters the angle between helices E and F in proteins such as calmodulin (CaM) ( Figure 2C ) (Grabarek, 2006; Gifford et al., 2007) . Unique to Rasgrp1, this linker is unusually short. Furthermore, biophysical studies revealed that Rasgrp1's EF2 does not bind calcium, that the E helix is non-existent in EF2, but instead has evolved as a critical loop forming an autoinhibitory interface with the C1 domain ( Figure 2D ,E) (Iwig et al., 2013) . The ENU-generated allele was named 'Rasgrp1
Anaef ' to reflect the combination of antinuclear antibody (ANA) production and the amino acid substitution in the EF hand. Genotyping of this mutation in multiple generations of B6 offspring (Figure 1-figure supplement 1B,C) demonstrated that inheritance of the Rasgrp1
Anaef allele was well correlated with the immunological abnormalities described above and below. ANAs were present in 70% of homozygous Rasgrp1
Anaef/Anaef mice and 35% of heterozygous Rasgrp1
Anaef/+ mice ( Figure 1D ), compared to 5% of wildtype B6 mice, indicating a gene dosage effect. The R519G substitution caused an approximate 40% decrease in Rasgrp1 protein levels in homozygous Rasgrp1
Anaef/Anaef thymocytes ( Figure 2F ). Since heterozygous Rasgrp1 +/− thymocytes express half the Rasgrp1 dosage ( Figure 2G ) but do not display an abnormal immune phenotype (Dower et al., 2000) , whereas heterozygous Rasgrp1 Anaef/+ mice do exhibit abnormal immune phenotypes ( Figure 1B,D) , we conclude that the immune dysregulation in mice bearing the Rasgrp1 Anaef allele is caused by the specific R519G alteration and not simply by a reduction of Rasgrp1 protein levels. In the remainder of the manuscript we discuss the analysis of homozygous Rasgrp1
Anaef/Anaef mice and refer to these as Rasgrp1 Anaef mice.
Rasgrp1
Anaef preserves Rasgrp1 function for T cell selection in the thymus
Analysis of Rasgrp1
Anaef mice revealed a striking contrast to the published Rasgrp1-deficient and Rasgrp1 d/d mouse models, which have T cell developmental defects that result in low thymic T cell (Iwig et al., 2013) . (E) Linear schematic of Rasgrp1 protein domains, phosphorylation site threonine 184, and position of R519G mutation in the second EF hand that evolved into a domain for autoinhibition. (F and G) Western blot for Rasgrp1 protein in thymocytes from
Rasgrp1
Anaef/Anaef (A/A), heterozygous Rasgrp1 Anaef/WT (A/+), heterozygous Rasgrp1 Null/WT (+/−), and wildtype (+/+) mice. Blot was reprobed for α tubulin as a loading control. Relative Rasgrp1 expression was calculated and is shown. Note the expression of Rasgrp1's typical doublet, thought to be due to alternative translation initiation (Poon and Stone, 2009) . Representative blots of at least three independent experiments. DOI: 10.7554/eLife.01020.005 output (Dower et al., 2000; Priatel et al., 2007; Fuller et al., 2012) . The frequency and number of mature CD4 + and CD8 + single positive (SP) thymocyte subsets was normal in Rasgrp1 Anaef mice, whereas these subsets were markedly decreased in Rasgrp1 −/− (knockout) mice analyzed in parallel ( Figure 3A,B Anaef (black columns) or CD45.2 + WT (white columns) thymocytes were determined and the mean ± SEM (n = 5 mice per group) is shown. See Figure 3 -figure supplement 1A for flow cytometry gates. (F) Mean ± SEM number of CD4SP thymocytes expressing TCR Vβ8, which is not superantigen reactive, or Vβ5 or Vβ11 that recognize endogenous retroviral superantigen presented by the I-E MHCII molecule, comparing B6 mice lacking I-E and B10.BR expressing the I-E (n = 3 mice per group compiled from two experiments). (G) Analysis of Jα usage in sorted CD4SP thymocytes of wildtype or Rasgrp1
Anaef mice following published methods. PCR was performed using serial 1:2 dilutions of template DNA with primer sets that reveal rearrangements proximal (Jα58, Jα49) or distal (Jα50, Jα22) to the two promoters. Figure 2G 
Anaef and CD45.1 + wildtype marrow, the Rasgrp1 Anaef thymocytes exhibited no competitive disadvantage as they matured from DP to SP cells ( Figure 3D ). Injection into mice of 5-bromo-2′-deoxyuridine (BrdU) to pulse-label a cohort of proliferating DP thymocytes followed by analysis on day 5 demonstrated that the kinetics of maturation into SP cells was unaffected by the Rasgrp1 Anaef mutation ( Figure 3E , Figure 3 -figure supplement 1A). There was also normal deletion of Vβ5 + and Vβ11 + SP thymocytes upon self-superantigen/I-E k recognition in B10.Br mice ( Figure 3F ) and similar usage of TCRα Jα segments in wildtype and Rasgrp1
Anaef CD4SP thymocyte populations ( Figure 3G , Figure 3 figure supplement 1B). Thus, analysis of the thymus of Rasgrp1
Anaef mice with a diverse TCR repertoire revealed no abnormalities in positive selection, Foxp3
+ T-regulatory (T-reg) cell differentiation or clonal deletion, in striking contrast to previously described Rasgrp1 mutations.
Anaef diminishes canonical Rasgrp1-Ras-ERK signaling in response to in vitro stimulation
Despite the normal thymic development in Rasgrp1
Anaef animals, there was a striking biochemical effect of the Rasgrp1
Anaef mutation on activation of the canonical Rasgrp1-Ras-ERK signaling pathway in a range of in vitro stimulation assays. GFP-tagged wildtype-or Anaef-Rasgrp1 was transiently expressed in RasGRP1-deficient Jurkat cells (JPRM441) (Roose et al., 2005) , which were either left unstimulated or stimulated with a combination of PMA (a synthetic analog of diacylglycerol) and ionomycin (a calcium ionophore). Gating on cells with different GFP intensities ( Figure 4 -figure supplement 1A) revealed that Rasgrp1
Anaef was hypomorphic (partial loss of function) for activating the Ras-ERK pathway: in GFP + cells expressing Rasgrp1
Anaef there was only low ERK phosphorylation (P-ERK) and this was only modestly increased when PMA and ionomycin were added ( Figure 4A ). By contrast, GFP + cells expressing high levels of wildtype Rasgrp1 vector induced 5-times higher P-ERK spontaneously and this was doubled by PMA and ionomycin stimulation. Next, we stably reconstituted the JPRM441 cell line, which expresses ∼10% of residual wildtype RasGRP1 protein (Roose et al., 2005) with Rasgrp1 (Roose et al., 2005) , clonal cell lines were stimulated with PMA followed by RasGTP pull-down assays, which demonstrated that Rasgrp1
Anaef decreased PMA-induced GTP-loading of Ras to levels below that of the nontransfected JPRM441 cells ( Figure 4B ). In the same transfected cell lines, PMA-induced P-ERK responses were decreased in Rasgrp1
Anaef expressing cells, most notable with the lower dose of PMA (PMA MED; 5 ng/ml) and contrasted the effective induction of P-ERK signals in Jurkat and JPRM441-WT-Rasgrp1 cells ( Figure 4C,D) .
Anaef expressing cells demonstrated less potent synergy in P-ERK levels when ionomycin was combined with a very low PMA stimulus (2 ng/ml) ( Figure 4E , Figure 4 
-figure supplement 1C). In fact, P-ERK responses in JPRM441-Rasgrp1
Anaef cells were more impaired than in the parental JPRM441 cells, indicating a dominant negative effect, which was also observed at the level of Ras activation ( Figure 4B ). We previously reported a dominant negative effect for ΔDAG-Rasgrp1, a form of Rasgrp1 lacking the DAG-binding C1 domain (ΔDAG) and we postulated that there may be competition with the residual ∼10% of wildtype RasGRP1 (Roose et al., 2005) . As Rasgrp1 is regulated by DAG-driven membrane recruitment (Ebinu et al., 1998; Roose et al., 2005) we examined this process for Rasgrp1
Anaef . EGFP-tagged wildtype or Anaef Rasgrp1-transfected JPRM441 cells were FACS sorted on low GFP expression to avoid overexpression artifacts and cells were allowed to adhere to coated slides. PMA stimulation resulted in membrane recruitment and cytoplasmic clearing of wildtype Rasgrp1; whereas these events were decreased for Rasgrp1
Anaef ( Figure 4F ). To test TCR-induced Ras-ERK signaling in thymocytes, we first stimulated thymocytes from wildtype or Rasgrp1
Anaef mice with anti-CD3 crosslinking antibodies and probed lysates for tyrosine-phosphorylated proteins to examine the global biochemical effects of the Rasgrp1 Anaef mutation. Both thymocyte populations demonstrated similar induction of total phospho-tyrosine patterns and similar activating phosphorylation of Lck and Zap-70 that lie upstream of Rasgrp1 ( Figure 5-figure supplement 1A ). Rasgrp1's GEF activity is also enhanced by phosphorylation on T184 (Roose et al., 2005; Zheng et al., 2005) . Using a new monoclonal antibody specific for P-T 184 -Rasgrp1 ( Figure 5-figure supplement 1B) we observed drastically impaired phosphorylation of T 184 -Rasgrp1, and reduced ERK phosphorylation in Rasgrp1
Anaef thymocytes ( Figure 5A ). By contrast, Rasgrp1 +/− thymocytes heterozygous for the null allele displayed readily detectable Rasgrp1-and ERK-phosphorylation ( Figure 5B) , demonstrating that the signaling defects in the Rasgrp1
Anaef thymocytes are much greater than when the amount of Rasgrp1 is simply halved. Thymocyte subset-specific P-ERK analyses revealed reduced anti-CD3-and PMA-induced responses in DP, CD4SP, and CD8SP Rasgrp1 Anaef thymocytes ( Figure 5C , Figure 5 -figure supplement 1C), echoing the cell line conclusion that the Anaef mutation results in a partial loss of function with respect to induced Ras-ERK signaling. When pressure was placed on TCR-Ras-ERK signaling for positive selection in vivo, by introducing any one of three different rearranged TCR transgenes that are prematurely expressed at higher than normal levels on DP thymocytes, a small decrease in positive selection was revealed in Rasgrp1
Anaef TCR-transgenic thymocytes compared to their wildtype controls ( Figure 5-figure supplement 2) . Collectively, these results lead to the surprising conclusion that the low affinity pMHC stimulation that drives physiological positive selection in vivo is remarkably robust to decreased Rasgrp1 activation of Ras-ERK. , and JPRM441 cells stably reconstituted with Anaef-or WT Rasgrp1 were left unstimulated or stimulated with 25 ng/ml PMA and RasGTP levels were determined through a RasGTP pull down assay. (C-E) The indicated cell lines were stimulated for 0, 1, 5, 10, or 30 min (see key) with a high (25 ng/ml, C), medium (5 ng/ml, D), or low dose (2 ng/ml, E) of PMA, or with 2 ng/ml PMA with ionomycin (1 μM) and stained for intracellular phosphorylated-ERK-1 and -2 (P-ERK), and analyzed by flow cytometry. Results for JPRM441-Rasgrp1Anaef clones #68 are shown, similar results were obtained with clone #69. (F) EGFP-tagged constructs were transiently transfected into JPRM441 and RasGRP1 localization was determined for unstimulated and PMA-stimulated cells as described in the text. 50 images for the 2-min PMA stimulation were scored in a blinded manner and plotted with RasGRP1-Anaef in the black columns. DOI: 10.7554/eLife.01020.008 The following figure supplements are available for figure 4: Figure 6A-C) . Further resolution of CD4 + subsets based on intracellular cytokine staining revealed that interferon-γ producing cells were increased in frequency by a similar magnitude as CD44 hi cells as a whole ( Figure 6D and data not shown). Thus, there was no evidence that the Rasgrp1
Anaef mutation skewed T-helper cells towards a Th1 phenotype, but simply increased the number of activated or memory/effector CD4 + cells. Staining for PD-1 and CXCR5, whose high expression on CD4 + cells identifies T follicular helper (T FH ) cells (Ramiscal and Vinuesa, 2013 ) revealed a dramatic expansion of these cells in Rasgrp1 Anaef mice ( Figure 6E ). However most of the increase in CD44 hi Foxp3 − CD4 + cells in Rasgrp1 Anaef mice was due to a 600% increase in cells that expressed intermediate levels of PD-1 and CXCR5, and hence are unlikely to be T FH cells, but were distinguished by high expression of the Helios transcription factor ( Figure 6E ). Helios is highly expressed in Foxp3 + T-reg cells (Thornton et al., 2010) , but in wildtype and Rasgrp1
Anaef mice Helios is also upregulated in a subset of Foxp3 − CD4 + cells, nearly all of which are CD44 hi ( Figure 6F ). Rasgrp1 Anaef greatly increased this Helios + CD44 hi Foxp3 − CD4 + population, Anaef and age-matched WT mice or Rasgrp1 +/− and age-matched WT mice stimulated with anti-CD3 antibodies. (C) P-ERK induction by in vitro stimulation followed by intracellular flow cytometric staining and electronic gating on thymocyte subsets. Thymocytes from Rasgrp1
Anaef and age-matched WT mice were stimulated with anti-CD3 antibody (5 μg/ml) and crosslinked using secondary antibody (Goat anti-hamster, 20 μg/ml) for the indicated time points, fixed, and stained for intracellular p-ERK. Histograms show P-ERK staining on electronically gated DP, CD4SP or CD8SP thymocytes. These conditions yielded low-levels of ERK phosphorylation that is typically observed for wildtype DP thymocytes. Numbers indicate the percentages of cells above the arbitrarily set reference point in the histograms so that it can be appreciated how many cells within each population cross this P-ERK threshold. Data is representative of three independent experiments. For PMA-induced responses see Anaef animals were intercrossed with mice bearing a null mutation in the BCR subunit, CD79a (Yabas et al., 2011) . In Rasgrp1
Anaef Cd79a null animals lacking B cells, accumulation of PD-1 + Helios + CD4 + T cells was profoundly suppressed ( Figure 7A,B) . Indeed, the Rasgrp1 Anaefdriven distortion in relative frequencies of naïve, effector/memory and regulatory subsets of CD4 splenocytes was rectified by the absence of B cells in Rasgrp1
Anaef Cd79a null mice ( Figure 7C,D) . By contrast, the elevated CD44 expression on naïve CD4
+ cells was still present ( Figure 7E ) indicating this is a constitutive effect of the Rasgrp1 Anaef mutation. The requirement for B cells could indicate they are needed as specialized antigen presenting cells, as is the case for T FH cells (Ramiscal and Vinuesa, 2013) , or that the Anaef mutation also acts in B cells since B cells also express Rasgrp1 (Stone, 2011) . To resolve these alternatives, we used bone marrow from Rasgrp1
Anaef Cd79a null animals mixed with wildtype Rasgrp1 +/+ marrow to generate chimeric mice where the Rasgrp1
Anaef mutation was excluded from B cells but present in most of the T cells (experimental group B in Figure 7F-I) , and compared these with control chimeras where all hematopoietic cells were Rasgrp1
Anaef or Rasgrp1 WT (groups A, C and D in Figure 7) . Despite having the Anaef mutation in the T but not B cells of group B mice, a high proportion developed antinuclear autoantibodies comparable to the control group D where both B and T cells carried the Anaef mutation ( Figure 7G) Figure 7I ). The accumulation of these activated CD4 T cells thus reflects a cell-autonomous effect of the Anaef mutation within the CD4 T cells and does not depend upon the Anaef allele being present in B cells.
CD44 expression is a sensitive reporter of mTOR activity in naïve T cells
Increased basal expression of the cell adhesion receptor, CD44, was a unique trait exhibited by naïve, CD62L-positive Rasgrp1
Anaef T cells ( Figure 1B) . CD44 expression normally increases during differentiation of DP thymocytes into SP T cells, attains higher levels on naïve CD4 T cells than on naïve CD8 cells, and increases further on activated/memory T cells, but little was known about what determines the level of CD44 expressed. In cancer cells CD44 has been described as an mTOR target (Hsieh et al., 2012) . In our ongoing peripheral blood screen of ENU mutagenized mouse pedigrees, we identified a strain, chino, with decreased CD44 expression on peripheral CD4 + CD62L hi cells but relatively normal T cell numbers and subsets ( Figure 8A ). This unusual phenotype mapped to a single nucleotide change (T to G) in exon 5 of the mechanistic target of rapamycin (Mtor) gene, introducing serine in place of isoleucine at position 205 in the fifth predicted HEAT domain of the protein (Knutson, 2010) ( Figure 8B ). This mTOR isoleucine residue is entirely conserved from mammals to yeast (Figure 8-figure supplement 1) . The mTOR HEAT-repeat domain forms a large superhelical structure that binds RAPTOR to recruit substrates such as S6 kinase for phosphorylation by the mTOR kinase domain (Kim et al., 2002; Adami et al., 2007) .
As the absence of Mtor is embryonic lethal in mice (Gangloff et al., 2004; Murakami et al., 2004) subtle decrease in mTOR activity, TCR-induced phosphorylation of ribosomal protein S6 (P-S6) was modestly decreased but not abolished in Mtor chino CD4 + splenocytes ( Figure 8D ). The numbers of DP, CD4SP and CD8SP thymocytes were normal in Mtor chino mice ( Figure 8E ). Whereas expression of CD69, CD5 and TCRβ on DP and SP thymocytes was normal, CD44 expression was decreased on Mtor chino CD4SP and CD8SP thymocytes ( Figure 8F ). CD44 expression on peripheral blood CD4 + T cells decreased in an Mtor chino allele dose-dependent manner ( Figure 8G ), demonstrating that CD44 expression is a highly sensitive reporter of small changes in basal mTOR activity in CD4 + T cells. This conclusion is reinforced by supplementary data from two studies: mice with a neo-insertion in an Mtor intron that decreases Mtor mRNA approximately 70% show a similar selective lowering of CD44 on CD4 + T cells and CD44 levels are also reduced on naïve, CD62L-positive T cells that are deficient for the mTOR activator Rheb or deficient for the mTOR-interacting protein Rictor (Delgoffe et al., 2011) . Furthermore, we found that pharmacological inhibition of mTOR with rapamycin in mice treated with low doses that avoid toxicity (Coenen et al., 2007; Araki et al., 2009) , resulted in a dose-dependent decrease in CD44 expression on wildtype and Rasgrp1 Anaef thymocytes ( Figure 8H ).
Rasgrp1
Anaef exaggerates basal mTOR-S6 signaling and CD44 expression in T cells
Our finding that tonic CD44 expression on naïve T cells sensitively reports small changes in mTOR activity prompted further analysis of this pathway in Rasgrp1 Anaef T cells. CD44 was elevated on Rasgrp1
Anaef DP and SP thymocytes, in diametric contrast to decreased CD44 on these cells in Rasgrp1 −/− knockout mice ( Figure 9A ,B) (Priatel et al., 2007) . A putative defect in regulatory T cells cannot explain the increased CD44 expression on naïve Rasgrp1 Anaef CD4 + cells, because in mixed chimeras bearing many wild-type Foxp3 + CD4 cells, CD44 expression was still increased on Rasgrp1 Anaef but not on co-resident wild-type CD62L + FOXP3 − CD4 + splenocytes ( Figure 9C ). The cell autonomous increase in CD44 expression was detectable on Rasgrp1
Anaef SP and DP thymocytes ( Figure 9 -figure supplement 1A,B) and even on CD4 + cells expressing a transgenic TCR ( Figure 9D ). Elevated CD44 expression on Rasgrp1
Anaef cells was selective: there were no distinguishable differences between wildtype and Rasgrp1
Anaef cells in CD69 and TCRβ, which are markers of cumulative Ras signaling (D' Ambrosio et al., 1994; Genot and Cantrell, 2000; Starr et al., 2003) , nor in CD5 expression, a sensitive reporter of TCR affinity and constitutive or tonic TCR signaling (Azzam et al., 1998; Mandl et al., 2013) (Figure 9E, Figure 9-figure supplement 1A,B) , and rapamycin treatment in vivo selectively reduced the increased CD44 expression on Rasgrp1
Anaef cells ( Figure 8H ) but did not impact TCR or CD69 expression (data not shown).
Consistent with the CD44 data, P-S6 levels in unstimulated TCRβ low (pre-selection) DP thymocytes were modestly increased in Rasgrp1
Anaef mice whereas they were decreased in cells from Rasgrp1 −/− mice ( Figure 10A ). CD44 levels gradually rise as T cells mature from DP to SP and peripheral naïve T cells, suggesting that CD44 expression may reflect basal or tonic signaling. Such signals can be visualized by constitutive tyrosine-phosphorylation of the TCRζ chains and other proteins (van Oers et al., 1993) , basal levels of ZAP70 recruitment to phosphorylated zeta chains (van Oers et al., 1994; Stefanova et al., 2002) , and tonic phosphorylation of ERK (Roose et al., 2003; Markegard et al., 2011) . Furthermore, these signals dissipate when T cells are rested in vitro in non-stimulatory medium (van Oers et al., 1993; Stefanova et al., 2002) . We investigated tonic mTOR-S6 signals and found substantial basal P-S6 levels in freshly isolated lymph node cells that decreased when cells were serum-starved in vitro Figure 10B) . A recent study reported that naive CD4 + T cells display a range of CD5 expression in which the CD5 high cells receive most tonic signal input and are most immune reactive (Mandl et al., 2013) . We first sorted CD44 low naïve CD4 + T cells into the most bright and most dim expression for CD5 and determined that CD5 high naïve CD4 + T cells have significantly more P-S6 than their CD5 low counterparts ( Figure 10C) . Next, dividing CD5 low and CD5 high naïve CD4 + T cells in equal 50-50% splits revealed that basal P-S6 was increased in Rasgrp1 Anaef , particularly in the CD5 low subset compared to wildtype cells ( Figure 10D) . The exact origin of tonic signals in T cells and its function being either immune stimulatory or immune suppressive is still an area of debate (Polic et al., 2001; Smith et al., 2001; Bhandoola et al., 2002; Stefanova et al., 2002; Hogquist et al., 2003) , but at least part of the tone appears to be generated by low affinity TCR binding to self pMHC (Stefanova et al., 2002) . To examine if self-peptide/MHCII recognition plays a role in the increased CD44 expression on Rasgrp1
Anaef naïve CD4 + T cells, we adoptively transferred a mixture of wild-type and Rasgrp1
Anaef splenocytes into wild-type or MHCII(H2-Aa)-deficient recipient mice ( Figure 10-figure supplement 1) .
Maintenance of CD5 expression on T cells requires contact with self pMHC (Smith et al., 2001; Mandl et al., 2012) and, as expected, CD5 expression on wildtype CD4 + CD62L + Foxp3 − T cells decreased in MHCII-deficient hosts ( Figure 10E) , consistent with the hypothesis that CD5 is a sensitive reporter of TCR signal strength. By contrast, CD44 levels were similar irrespective of MHCII expression in the adoptive hosts, and CD44 levels remained higher on Rasgrp1
Anaef than co-transferred wild-type cells in both contexts ( Figure 10E ). These data reveal constitutively increased expression of two reporters of mTOR activity in Rasgrp1
Anaef naïve CD4 + T cells: the well-established reporter P-S6 and the reporter clarified here, CD44. The fact that the Rasgrp1
Anaef -driven increase in CD44 is retained in the absence of MHCII suggests that this tonic signal is at least partially independent of triggering of TCRs by self-pMHC.
CD44
+ Anaef -driven increase in CD44 expression in these naïve T cells ( Figure 11A) . The Mtor chino mutation alone resulted in a decrease in numbers of splenocytes, including CD4 + cells, as was observed in mice with reduced Mtor mRNA , but the relative proportions of the CD4 + subsets examined were normal ( Figure 11B ). Whereas Rasgrp1
Anaef mice with normal mTOR accumulated a high frequency of CD44 hi Foxp3 − CD4 + splenocytes, including the prominent PD-1 + Helios + subset, this was corrected down to normal numbers in Rasgrp1
Anaef Mtor chino double mutants ( Figure 11B,C) . Moreover, in bone marrow chimeras bearing Rasgrp1
Anaef Mtor chino double-mutant hematopoietic cells, the frequency of animals with antinuclear autoantibodies was corrected to the low frequency observed in control chimeras with wildtype Rasgrp1 and Mtor ( Figure 11D) . Collectively, these results establish that accumulation of CD44
hi Helios + PD-1 + CD4 + cells and autoantibodies induced by Rasgrp1 Anaef is sensitive to small differences in mTOR signaling.
Discussion
The findings here reveal a new role for Rasgrp1 in the cell-intrinsic regulation of peripheral CD4 + T cells. By analyzing a missense mutation in the Rasgrp1 EF-hand, the results dissociate this new function of Rasgrp1 from its well-known role in thymic positive selection. While the Anaef EF-hand mutation did decrease Rasgrp1 activation of Ras and ERK when thymocytes were stimulated acutely by antibodies to CD3 or with PMA in vitro, the activity of this pathway during physiological positive selection in vivo RFI on unstimulated CD4SP thymocytes of WT or Rasgrp1 Anaef mice after 7 days of treatment with the indicated rapamycin doses. Untreated control was set at 1. ***p<0.005, n.s. = non significant. DOI: 10.7554/eLife.01020.015 The following figure supplements are available for figure 8:
Figure supplement 1. Alignment of HEAT5 domains in mTOR. DOI: 10.7554/eLife.01020.016 Figure 8 . Continued remained sufficient for normal numbers of single positive thymocytes and peripheral T cells to form even under competitive reconstitution conditions. T cell lymphopenia and sparse T cell repertoires secondary to defective positive selection potentially explain the autoantibodies observed in mice where Rasgrp1 is entirely absent or C-terminally deleted (Dower et al., 2000; Coughlin et al., 2005; Priatel et al., 2007; Fuller et al., 2012) , and in animals with missense mutations in ZAP-70 or LAT (Aguado et al., 2002; Sommers et al., 2002; Sakaguchi et al., 2003; Siggs et al., 2007) . By contrast, the normal thymic development coupled with experiments in mixed bone marrow chimeras where wild-type and mutant T cells co-exist rules out this possibility for the Rasgrp1 Anaef mutation, and shows that peripheral CD4 cells are intrinsically dysregulated. By a combination of biochemical and genetic studies, we identify overactive mTOR signaling within naïve CD4 T cells as a key component for Rasgrp1
Anaef to drive two abnormalities: (1) a constitutive increase in CD44 expression in naïve CD4 T cells and (2) a gradual accumulation of peripheral Helios + CD44 hi CD4 cells and autoantibodies. Anaef , 13 wildtype, and 3 Rasgrp1 −/− mice compiled from seven experiments. In each experiment, the mean CD44 expression for the wildtype group was taken to be one, and values for individual mice were normalized to this. Unpaired Student's t tests were used to compare Rasgrp1
Anaef and Rasgrp1 −/− with the wildtype group. **p<0.005, ***p<0.0005. (C) CD44 MFI on CD62L
+ splenocytes from mixed bone marrow chimeras described in Figure 7F . Statistical comparisons used paired t tests within, and unpaired t tests between, groups of chimeras (n = 9 for both groups); ***p<0.001, **p<0. 
Rasgrp1
Anaef 's effect on Ras/ERK signaling in vivo was much milder than expected from its effects in in vitro assays. In response to relatively strong in vitro stimuli, the Rasgrp1
Anaef mutation results in impaired membrane recruitment and T 184 phosphorylation of Rasgrp1 as well as reduced activation of Ras-ERK, establishing that Rasgrp1
Anaef is a hypomorphic (partial loss-of-function) allele under these conditions. By contrast, in vivo, Rasgrp1
Anaef did not alter CD69 and TCRβ induction or positive selection of thymocytes, unlike the C-terminally deleted (Rasgrp1 d/d ) and knockout (Rasgrp1 −/− ) alleles which caused moderate and severe decreases in these processes, respectively. This may indicate that the cumulative Ras-ERK signals required for these events are sufficiently buffered or robust that they tolerate a modest reduction in Rasgrp1's Ras activating activity. Only when a TCR transgene was Figure 11 . Continued on next page prematurely expressed at higher than normal levels in DP thymocytes was there a measurable deficit in positive selection, and even under these conditions there was a small decrease in positive selection compared even to the subtle Zap70 murdock mutation (Siggs et al., 2007) . This is surprising given that the induction of these signals involves low affinity pMHC binding by the TCR, which might be expected to be particularly sensitive to small changes in Ras-ERK signal strength (Kortum et al., 2013) .
CD44 expression on thymocytes is decreased in the complete absence of Rasgrp1 (Figure 9 ) (Priatel et al., 2007) and increased by oncogenic Ras (Kindler et al., 2008; Zhang et al., 2009; Wang et al., 2011) establishing that CD44 expression in thymocytes is positively regulated by Ras. T-cell CD44 expression is also sensitive to mTOR activity, being reduced by the partial loss-of-function Mtor chino ( Figure 8 ) and Mtor tm1Lgm alleles, and dramatically decreased in the absence of Rictor (Delgoffe et al., 2011) , a binding partner of mTOR. Rasgrp1
Anaef thymocytes and naïve CD4 T cells have increased CD44 and P-S6 expression, suggesting that the Anaef mutation increases either Rasgrp1/Ras/ERK signaling or PI-3-kinase/mTOR/S6 signaling, or both. Our recent biophysical studies revealed that Rasgrp1's EF hands keep the protein in an autoinhibited, dimeric state, and modeling indicates that calcium-binding to the EF domain would relieve autoinhibition (Iwig et al., 2013) . Thus, Rasgrp1's EF hands play both stimulatory-and inhibitory-roles that may result in the EF2 substitution in Rasgrp1
Anaef decreasing maintenance of the autoinhibited state in the absence of strong TCR stimuli and decreasing RasGRP1 activation during strong TCR stimulation. Evidence exists for multiple intersections between the RasGRP1/Ras/ERK/RSK and PI-3-kinase/mTOR/S6 pathways, including at the level of Ras with PI-3-kinase (Castellano and Downward, 2010) and at the level of RSK with S6 (Salmond et al., 2009) . While the mechanism is currently unclear, the current evidence suggests that Rasgrp1
Anaef 's gain-of-function in naïve T cells in the absence of strong TCR stimulation-and apparently in the absence of MHCII ligands for the TCR ( Figure 10E )-activates S6-CD44 more than it activates ERK-CD69.
In T cells, the mTOR pathway is activated by strong TCR stimulation (Gorentla et al., 2011) and is required for efficient differentiation of naïve CD4 cells into effector cells (Delgoffe et al., 2009 ). T-cellspecific deletion of Tsc1, a negative regulator of mTOR, results in increased levels of P-S6 and an exuberant response to TCR stimulation in naïve T cells (Figure 7) , these T cells might require B cells as specialized APCs or they might require Fc receptor-dependent enhancement of antigen presentation by antibodies (Silva et al., 2011) .
Given the huge number of missense variants in each person (The 1000 Genomes Project Consortium, 2010), patients with autoimmune diseases are more likely to have point mutations in various genes than complete loss of gene expression. This new Rasgrp1
Anaef mouse model adds to an emerging category of animal models with point mutations in TCR signaling proteins, along with Zap70 skg (Sakaguchi et al., 2003) , Zap70 murdock and Zap70 mrtless hypomorphic alleles (Siggs et al., 2007) , LAT Y136F mice (Aguado et al., 2002; Sommers et al., 2002) , and Card11 unmodulated mice (Jun et al., 2003) , where a partial deficit in T cell signaling precipitates autoimmunity or allergy. RASGRP1 splice variants have been documented for patients with SLE (Yasuda et al., 2007) and abnormal microRNA-driven downregulation of Rasgrp1 expression may play a role in aberrant DNA methylation in Lupus CD4 + T cells (Pan et al., 2010) . In addition, RASGRP1-linked SNVs have been associated with autoimmune diabetes and thyroid disease (Qu et al., 2009; Plagnol et al., 2011) . Of the 13 uncharacterized RASGRP1 missense SNVs currently known, rs62621817 is of particular interest here since it causes a missense variation in RasGRP1's first EF hand, changing a conserved, negatively charged aspartic acid into a valine residue. We propose that Rasgrp1
Anaef mice may provide a useful model system for further studies to help elucidate how RASGRP1 variants contribute to autoimmune disease, and to help target future efforts to modulate this pathway pharmacologically. Anaef and Mtor chino strains were established through ethylnitrosourea (ENU)-mediated mutagenesis of B6 mice at the Australian National University as previously described (Randall et al., 2009) .
Genetic mapping of the Anaef mutation
Affected Rasgrp1
Anaef mice were crossed onto the CBA/J background to generate heterozygous F1 mice. F1 mice were intercrossed to yield mice homozygous for the Anaef mutation and carrying a mix of C57BL/6 and background CBA/J single nucleotide polymorphisms (SNPs). Genomic DNA samples isolated from both affected and unaffected mice were used as templates for SNP mapping at the Genomics Institute of the Novartis Research Foundation (San Diego, CA). SNP markers were spaced approximately every 3-5 Mbp throughout the genome. Once a defined interval was established, the Rasgrp1 encoding gene was sequenced from genomic DNA from both affected Anaef and WT mice. All exons were amplified by PCR with primers designed to include intronic RNA splice donor and acceptor sites. Exome enrichment using the SureSelect Mouse Exome kit (G7550A-001; Agilent, Santa Clara, CA), sequencing using the Illumina HiSeq 2000 (Illumina, San Diego, CA), and computational analysis to detect novel single-nucleotide variants were performed as described previously (Andrews et al., 2012) .
Genotyping
Roose lab Anaef mice were genotyped using MS-PCR. Primers were combined in a single reaction with Taq, Taq buffer and dNTPs (all New England BioLabs, Ipswich, MA). Goodnow lab Anaef mice were genotyped by APF Genomics Services following the manufacturer's instructions for Amplifluor PCR (SNP FAM/JOE; Millipore, Billerica, MA).
Transfections and stable cell lines
Transfections and creation of stable cell lines was performed as previously described (Roose et al., 2005) .
Antinuclear antibody testing
Diluted mouse plasma was applied to HEp-2 slides (Inova, San Diego, CA). AlexaFluor488-conjugated goat anti-mouse IgG (Invitrogen, Carlsbad, CA) was added and slides mounted with fluorescence mounting medium (Dako Australia). Photos were taken using an Olympus IX71 microscope and WIB filter with 20 × lens and exposure time of 1/25 s.
Flow cytometry
Suspensions of splenocytes (depleted of erythrocytes by brief osmotic lysis) or thymocytes were incubated with cocktails of anti-mouse antibodies specific for: CD44, CD4, CD45.1, CD45.2, CD5, CD62L, CD69, TCRβ, PD-1, TCR Vβ5, TCR Vβ8, TCR Vβ11, B220, CD95, GL-7, B220 (BD Pharmingen Franklin Lakes, NJ or BioLegend San Diego, CA) or CD8 (BD Pharmingen and UCSF Monoclonal Antibody Core, clone YTS169.4) conjugated to AlexaFluor700, APC-780 or APCCy7, PE-Cy7, APC, PerCPCy5.5, FITC, PE, Pacific Blue or biotin. Biotinylated antibodies were detected in another incubation step with streptavidin conjugated to Qdot605 (Invitrogen) or BV605 (BioLegend). Cells expressing the 3A9 TCR transgene were detected using the 1G12 (mouse IgG1) antibody (ATCC, Manassas, VA) followed by another incubation in anti-mouseIgG1 (A85.1). To detect intracellular proteins, cells were fixed and permeabilized using a Foxp3 staining kit (eBioscience, San Diego, CA), then labeled with antibodies specific for Foxp3 (FJK-16s; eBioscience), Helios (clone 22F6; Biolegend), IFNγ, IL-4, IL-2 or IL-17 (all BD Pharmingen). Flow cytometry data was acquired on a FACSort (Becton Dickinson) or an LSR Fortessa system and analyzed with FlowJo v8 (Treestar, Ashland, OR).
Cell stimulations
Cells were stimulated using 25 ng/ml (HIGH), 5 ng/ml (MED), or 2 ng/ml (LOW) PMA (Calbiochem) with/without ionomycin (10 μM, Sigma, St. Louis, MO), or with 100 ng/ml PMA for Phospho-S6 assays. To mimic TCR engagement, cells were pre-labeled using anti-CD3 primary antibody (10 μg/ml, UCSF Monoclonal Antibody Core, clone 2C11) and crosslinking was achieved using goat anti-hamster antibody (10 μg/ml, Jackson ImmunoResearch). For intracellular cytokine detection by flow cytometry, splenocytes were stimulated in complete medium for 4 hr at 37°C with PMA (100 ng/ml; Sigma), ionomycin (500 ng/ml; Sigma) and GolgiStop (1/1000; BD), then labeled as described above.
Flow cytometry for phosphorylated proteins
Procedure was performed as described in Das et al., (2009) . Cells were fixed using Cytofix Cell Fixative (BD Biosciences). Cells were permeabilized using 90% Methanol. Primary staining for phospho-Erk occurred using rabbit anti-mouse p-Erk antibody (#4377S; Cell Signaling) followed by staining with goat anti-Rabbit PE (Jackson ImmunoResearch, West Grove, PA). For analysis of tonic and PMA induced S6 phosphorylation by FACS, single-cell suspensions were prepared from thymus. Half of the cells were fixed in warm cytofix (BD Biosciences) immediately after harvesting and reserved for tonic signaling analysis. The remaining cells were then counted, and 10 6 cells/sample were stimulated with PMA for 3 min, followed by fixation. Stimulated and unstimulated cells were then washed three times with cytoperm buffer (BD Biosciences) and incubated on ice in this buffer with a rabbit polyclonal antibody against phosphorylated S6 (cell signaling) for 45 min. The cells were then washed twice with cytoperm and incubated for an additional 45 min in cytoperm buffer containing an APC-conjugated goat anti-rabbit secondary antibody, as well as anti CD8-FITC, CD4, PE-Cy7 and TCRβ-PE. Cells were washed twice and analyzed in an LSR Fortessa system.
Ras pulldown
Activation of Ras was analyzed using a RasGTP pulldown assay (Upstate Biotechnology, Lake Placid, NY) as previously described (Roose et al., 2005) .
Western blotting
Cells were lysed using Nonidet-P40 lysis buffer (1%) supplemented with protease and phosphatase inhibitors. Lysates were run on 10% acrylamide Bis-Tris gels and transferred onto PDVF filter (Millipore, Immobilon-P). Blots were probed for Rasgrp1 (M199; Santa Cruz, Dallas, TX), Alpha tubulin (Sigma), phospho-tyrosine (In house antibody prep, clone 4G10), phospho-Zap70 (Y493; Cell Signaling, Danvers, MA), phospho-PLCγ (Y783; Cell Signaling) and phospho-Lck (Y416; Cell Signaling), anti-ERK (pan-Erk) antibody (BD Transduction labs, clone 16/ERK). Rabbit anti-human Rasgrp1 (clone E80) was produced by Epitomics, Inc. (Burlingame, CA, USA). Mouse anti-Rasgrp1 p-T184 (clone JR-pT184RG1-4G7) was produced by AnaSpec (Fremont, CA, USA). Signal from primary antibodies detected using HRP conjugated secondary antibodies: Sheep anti-mouse HRP (GE Healthcare, Cleveland, OH) and goat antirabbit HRP (SouthernBiotech, Birmingham, AL). Blots were developed using Pierce ECL Western Blotting Substrate (ThermoScientific, Waltham, MA) and images recorded using a chemiluminescence imager (LAS-4000; Fuji).
Bone marrow chimeras
Bone marrow was collected, and in some experiments, depleted of T cells and NK cells by magnetic labelling using biotinylated anti-TCRβ and anti-NK1.1 and streptavidin microbeads followed by passage through a MACS LD column (Miltenyi Biotec, Germany). Recipient mice were irradiated with X-rays (2 doses of 4.5 Gy given 4 hr apart) then injected intravenously (i.v.) with 2 × 10 6 bone marrow cells that were either from single or multiple donors as described in the text.
Rapamycin treatment
Suboptimal doses of rapamycin (Coenen et al., 2007; Araki et al., 2009) were prepared on day 0 in sufficient quantity for all injections in one experiment. The appropriate rapamycin stock volume was diluted to the indicated concentrations in DMSO (15.4%), Cremaphor (15.4%) and water (69.2%), and aliquoted in six equal portions (one aliquot per injection) and frozen. Mice were injected on days 0, 1, 2, 3, 5 and 7, and then sacrificed on day 8. Thymocytes were harvested and analyzed as before.
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